In addition, hydrophobic contacts were observed between the N -trimethyl moiety of TML and the sidechains of residues L17, I66, V69, N70, L73, L117, F120, and K124 lining the cavity ( Fig
The renoprotective effect of GLP-1RA can be achieved by reducing urinary protein levels and the glomerular filtration rate (66, 67)
V.SzelingerS.JoshipuraK.et al
Not sure how to start the conversation
A third argument for adopting edible organisms for GLP-1 delivery would be to increase global accessibility
Safety Considerations and Future Outlook As with all pharmacotherapy for obesity and T2D, establishing cardiovascular safety and demonstrating improvements in meaningful clinical outcomes will be essential, particularly as cardiovascular outcome trials have not yet been completed with multi-agonists (although data are expected soon for tirzepatide: SURPASS-CVOT [T2D] in 2025